|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
Green tea is able to stop the scent of garlic or onion from causing bad breath.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.